4//SEC Filing
Lawton Alison Frances 4
Accession 0001209191-23-040328
CIK 0001636282other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:30 PM ET
Size
5.8 KB
Accession
0001209191-23-040328
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+1,950,000→ 1,950,000 totalExercise: $0.30Exp: 2033-06-22→ Common Stock (1,950,000 underlying)
Footnotes (2)
- [F1]This option award is contingent upon receiving stockholder approval of the amendment and/or restatement of the 2016 Equity Incentive Plan to increase the number of shares available for issuance thereunder.
- [F2]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 22, 2023, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:30 PM ET
- Size
- 5.8 KB